VYBÍHAL, Václav, Vilém JURÁŇ, Tomáš KAZDA, Marek SOVA, Pavel FADRUS, Martin SMRČKA, Martin PISKÁČEK and Andrea KNIGHT. Blockade of PD-L1 and B7-H3 checkpoint inhibitor ligands in glioblastoma. In International Cancer Immunotherapy Conference CICON23. 2023.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Blockade of PD-L1 and B7-H3 checkpoint inhibitor ligands in glioblastoma
Authors VYBÍHAL, Václav (203 Czech Republic, belonging to the institution), Vilém JURÁŇ (203 Czech Republic, belonging to the institution), Tomáš KAZDA (203 Czech Republic, belonging to the institution), Marek SOVA (203 Czech Republic, belonging to the institution), Pavel FADRUS (203 Czech Republic, belonging to the institution), Martin SMRČKA (203 Czech Republic, belonging to the institution), Martin PISKÁČEK (40 Austria, belonging to the institution) and Andrea KNIGHT (203 Czech Republic, belonging to the institution).
Edition International Cancer Immunotherapy Conference CICON23, 2023.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30102 Immunology
Country of publisher Italy
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/23:00134682
Organization unit Faculty of Medicine
Keywords in English PD-L1; B7-H3; checkpoint inhibitor ligands; glioblastoma
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 6/5/2024 10:21.
Abstract
Blockade of PD-L1 and B7-H3 checkpoint inhibitor ligands in glioblastoma - conference abstract.
Links
NV19-05-00410, research and development projectName: Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme
Investor: Ministry of Health of the CR
PrintDisplayed: 24/7/2024 11:29